Peripheral Stem Cell Transplantation Plus Filgrastim in Treating Patients With Acute or Chronic Myelogenous Leukemia

NCT00002833 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

53

Enrollment

OTHER

Sponsor class

Conditions

Graft Versus Host Disease
Leukemia
Myelodysplastic Syndromes

Interventions

BIOLOGICAL: Filgrastim
DRUG: Cladribine
DRUG: Cyclosporine
DRUG: Cytarabine (Ara-C)
DRUG: Fludarabine Phosphate
DRUG: Idarubicin
DRUG: Methylprednisolone
PROCEDURE: Peripheral Blood Stem Cell Transplantation

Sponsor

M.D. Anderson Cancer Center

Collaborators

[object Object]